CTBO (Cantabio Pharmaceuticals) Total Inventories: $0.00 Mil (As of Dec. 2018)


What is Cantabio Pharmaceuticals Total Inventories?

Cantabio Pharmaceuticals CTBO Total Inventories is $0.00 Mil as of Dec. 2018.

Cantabio Pharmaceuticals's total inventories for the quarter that ended in Dec. 2018 was $0.00 Mil. Cantabio Pharmaceuticals's average total inventories from the quarter that ended in Sep. 2018 to the quarter that ended in Dec. 2018 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Cantabio Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in Dec. 2018 was $-101.68.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cantabio Pharmaceuticals  (OTCPK:CTBO) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Cantabio Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2018 is

Net-Net Working Capital Per Share (Q: Dec. 2018 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.283+0.75 * 0+0.5 * 0-2.215
-0-0)/0.019
=-101.68

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cantabio Pharmaceuticals's Days Inventory for the three months ended in Dec. 2018 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2018 )/Cost of Goods Sold (Q: Dec. 2018 )*Days in Period
=0/0*365 / 4
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cantabio Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2018 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2018 ) / Average Total Inventories (Q: Dec. 2018 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cantabio Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2018 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2018 ) / Revenue (Q: Dec. 2018 )
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Cantabio Pharmaceuticals Total Inventories Related Terms

Cantabio Pharmaceuticals Total Inventories Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Total Inventories Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Total Inventories
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cantabio Pharmaceuticals Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →
What does a Total Inventories of $0.00 Mil mean?
Cantabio Pharmaceuticals (CTBO) has a Total Inventories of $0.00 Mil as of Dec. 2018. The total amount of inventory as recorded on a company's balance sheet. View historical data for Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Total Inventories too high?
Cantabio Pharmaceuticals' current Total Inventories is $0.00 Mil.
How does Cantabio Pharmaceuticals' Total Inventories compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Total Inventories of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Cantabio Pharmaceuticals and its competitors. Cantabio Pharmaceuticals's current Total Inventories is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Total Inventories of $0.00 Mil. The current Total Inventories is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Total Inventories is $0.00 Mil as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.